Haoxi Health Technology Limited Financials
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Haoxi Health Technology Limited has an operating margin of -6.1%, meaning the company retains $-6 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from 3.5% the prior year.
Haoxi Health Technology Limited's revenue declined 32.4% year-over-year, from $48.5M to $32.8M. This contraction results in a growth score of 0/100.
Haoxi Health Technology Limited carries a low D/E ratio of 0.02, meaning only $0.02 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 5.05, Haoxi Health Technology Limited holds $5.05 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
Haoxi Health Technology Limited earns a strong 22.3% return on equity (ROE), meaning it generates $22 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 89/100. This is up from 11.5% the prior year.
Haoxi Health Technology Limited passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Haoxi Health Technology Limited generates $-0.87 in operating cash flow (-$3.4M OCF vs $3.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Haoxi Health Technology Limited earns $-43.5 in operating income for every $1 of interest expense (-$2.0M vs $46K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
This page shows Haoxi Health Technology Limited (HAO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Haoxi Health Technology Limited generated $32.8M in revenue in fiscal year 2025. This represents a decrease of 32.4% from the prior year.
Haoxi Health Technology Limited's EBITDA was -$1.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 194.2% from the prior year.
Haoxi Health Technology Limited reported $3.9M in net income in fiscal year 2025. This represents an increase of 200.1% from the prior year.
Haoxi Health Technology Limited earned $1.32 per diluted share (EPS) in fiscal year 2025. This represents an increase of 24.5% from the prior year.
Haoxi Health Technology Limited held $8.6M in cash against $307K in long-term debt as of fiscal year 2025.
Haoxi Health Technology Limited's gross margin was 2.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.8 percentage points from the prior year.
Haoxi Health Technology Limited's operating margin was -6.1% in fiscal year 2025, reflecting core business profitability. This is down 9.6 percentage points from the prior year.
Haoxi Health Technology Limited's net profit margin was 11.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 9.2 percentage points from the prior year.
Haoxi Health Technology Limited's ROE was 22.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 10.8 percentage points from the prior year.
Haoxi Health Technology Limited invested $80K in research and development in fiscal year 2025. This represents a decrease of 0.6% from the prior year.
HAO Income Statement
| Metric | Q2'25 | Q2'24 | Q2'23 |
|---|---|---|---|
| Revenue | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A |
| EPS (Diluted) | N/A | N/A | N/A |
HAO Balance Sheet
| Metric | Q2'25 | Q2'24 | Q2'23 |
|---|---|---|---|
| Total Assets | $21.6M-2.1% | $22.1M+394.3% | $4.5M |
| Current Assets | $19.6M-1.1% | $19.8M+439.5% | $3.7M |
| Cash & Equivalents | $8.6M-5.3% | $9.1M+656.0% | $1.2M |
| Inventory | N/A | N/A | N/A |
| Accounts Receivable | $460K-37.3% | $734K+9377.9% | $8K |
| Goodwill | N/A | N/A | N/A |
| Total Liabilities | $4.2M+26.9% | $3.3M+14.7% | $2.9M |
| Current Liabilities | $3.9M+18.0% | $3.3M+27.8% | $2.6M |
| Long-Term Debt | $307K+1.9% | $302K+21.1% | $249K |
| Total Equity | $17.4M-7.3% | $18.7M+1096.5% | $1.6M |
| Retained Earnings | $4.6M+837.5% | $491K+186.3% | -$568K |
HAO Cash Flow Statement
| Metric | Q2'25 | Q2'24 | Q2'23 |
|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A |
HAO Financial Ratios
| Metric | Q2'25 | Q2'24 | Q2'23 |
|---|---|---|---|
| Gross Margin | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A |
| Current Ratio | 5.05-1.0 | 6.02+4.6 | 1.43 |
| Debt-to-Equity | 0.02-0.2 | 0.18+0.0 | 0.16 |
| FCF Margin | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Haoxi Health Technology Limited's annual revenue?
Haoxi Health Technology Limited (HAO) reported $32.8M in total revenue for fiscal year 2025. This represents a -32.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Haoxi Health Technology Limited's revenue growing?
Haoxi Health Technology Limited (HAO) revenue declined by 32.4% year-over-year, from $48.5M to $32.8M in fiscal year 2025.
Is Haoxi Health Technology Limited profitable?
Yes, Haoxi Health Technology Limited (HAO) reported a net income of $3.9M in fiscal year 2025, with a net profit margin of 11.8%.
What is Haoxi Health Technology Limited's earnings per share (EPS)?
Haoxi Health Technology Limited (HAO) reported diluted earnings per share of $1.32 for fiscal year 2025. This represents a 24.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Haoxi Health Technology Limited's EBITDA?
Haoxi Health Technology Limited (HAO) had EBITDA of -$1.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Haoxi Health Technology Limited have?
As of fiscal year 2025, Haoxi Health Technology Limited (HAO) had $8.6M in cash and equivalents against $307K in long-term debt.
What is Haoxi Health Technology Limited's gross margin?
Haoxi Health Technology Limited (HAO) had a gross margin of 2.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Haoxi Health Technology Limited's operating margin?
Haoxi Health Technology Limited (HAO) had an operating margin of -6.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Haoxi Health Technology Limited's net profit margin?
Haoxi Health Technology Limited (HAO) had a net profit margin of 11.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Haoxi Health Technology Limited's return on equity (ROE)?
Haoxi Health Technology Limited (HAO) has a return on equity of 22.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Haoxi Health Technology Limited's operating cash flow?
Haoxi Health Technology Limited (HAO) generated -$3.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Haoxi Health Technology Limited's total assets?
Haoxi Health Technology Limited (HAO) had $21.6M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Haoxi Health Technology Limited spend on research and development?
Haoxi Health Technology Limited (HAO) invested $80K in research and development during fiscal year 2025.
What is Haoxi Health Technology Limited's current ratio?
Haoxi Health Technology Limited (HAO) had a current ratio of 5.05 as of fiscal year 2025, which is generally considered healthy.
What is Haoxi Health Technology Limited's debt-to-equity ratio?
Haoxi Health Technology Limited (HAO) had a debt-to-equity ratio of 0.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Haoxi Health Technology Limited's return on assets (ROA)?
Haoxi Health Technology Limited (HAO) had a return on assets of 17.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Haoxi Health Technology Limited's cash runway?
Based on fiscal year 2025 data, Haoxi Health Technology Limited (HAO) had $8.6M in cash against an annual operating cash burn of $3.4M. This gives an estimated cash runway of approximately 31 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Haoxi Health Technology Limited's Piotroski F-Score?
Haoxi Health Technology Limited (HAO) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Haoxi Health Technology Limited's earnings high quality?
Haoxi Health Technology Limited (HAO) has an earnings quality ratio of -0.87x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Haoxi Health Technology Limited cover its interest payments?
Haoxi Health Technology Limited (HAO) has an interest coverage ratio of -43.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Haoxi Health Technology Limited?
Haoxi Health Technology Limited (HAO) scores 58 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.